Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibodies and ischemic stroke.

R L Brey1

  • 1Division of Neurology, University of Texas Health Science Center, San Antonio 78284-7883.

Heart Disease and Stroke : a Journal for Primary Care Physicians
|November 1, 1992
PubMed
Summary

Antiphospholipid antibodies (aPL) are linked to recurrent thrombosis. While their role in clot formation is suggested, optimal treatment for associated thrombosis remains unclear, often requiring aggressive therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid antibodies and the brain: a consensus report.

Lupus·2011
Same author

International consensus for a definition of disease flare in lupus.

Lupus·2010
Same author

Antiphospholipid syndrome and the brain in pediatric and adult patients.

Lupus·2010
Same author

Evaluation and treatment of seizures in patients with systemic lupus erythematosus.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.

International journal of clinical practice·2007
Same author

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Journal of thrombosis and haemostasis : JTH·2006

Area of Science:

  • Immunology
  • Hematology
  • Vascular Medicine

Background:

  • Antiphospholipid antibodies (aPL) are associated with recurrent venous and arterial thrombosis.
  • Cerebral thrombosis shows a skewed frequency in arterial circulation involvement.
  • Clinical indicators for aPL evaluation include young adult stroke, recurrent thrombosis/miscarriage, and thrombocytopenia.

Purpose of the Study:

  • To summarize the association of antiphospholipid antibodies with thrombosis.
  • To highlight clinical and laboratory findings suggestive of aPL.
  • To discuss the potential role of aPL in thrombosis pathogenesis and management.

Main Methods:

  • Literature review of studies on antiphospholipid antibodies and thrombosis.
  • Analysis of clinical presentations and laboratory findings associated with aPL.
  • Discussion of pathogenetic mechanisms and therapeutic strategies.

Main Results:

  • aPL are strongly linked to recurrent thrombotic events.
  • Specific clinical clues and laboratory abnormalities aid in aPL detection.
  • Evidence suggests aPL's direct role in thrombosis pathogenesis.

Conclusions:

  • Antiphospholipid antibody-associated thrombosis requires careful evaluation.
  • Diagnosis may involve specific laboratory tests beyond routine screening.
  • Optimal management strategies are still under investigation, sometimes necessitating aggressive treatments.

Related Experiment Videos